Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review

Anna Pia Delli Bovi1, Francesca Marciano1,2, Claudia Mandato3

  • 1Pediatrics Section, Department of Medicine and Surgery, Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.

Frontiers in Medicine
|March 15, 2021
PubMed

Insights

Non-alcoholic fatty liver disease (NAFLD) involves oxidative stress (OS) and gut microbiota. Current treatments are limited, but antioxidants and gut-targeting therapies show promise for managing this complex liver condition.

Area of Science:

  • Hepatology
  • Oxidative Stress Research
  • Gastroenterology

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition lacking adequate therapeutic strategies.
  • Oxidative stress (OS) and gut microbiota dysbiosis are key contributors to NAFLD pathogenesis.
  • The gut-liver axis plays a significant role in NAFLD development and progression.

Purpose of the Study:

  • To explore the intricate interplay between oxidative stress and other pathogenetic factors in NAFLD.
  • To review current and emerging therapeutic approaches for NAFLD.
  • To highlight the potential of precision medicine in tailoring NAFLD treatments.

Main Methods:

  • Review of existing literature on NAFLD pathogenesis, focusing on oxidative stress and gut microbiota.
  • Analysis of the role of reactive oxygen species (ROS) generators and antioxidant defenses.
  • Evaluation of therapeutic strategies including antioxidants, dietary interventions, and microbiota modulation.

Main Results:

  • Reactive oxygen species (ROS) contribute to NAFLD progression, linked to lipotoxicity and inflammation.
  • Antioxidant defenses can be overwhelmed by ROS, influenced by genetic and epigenetic factors.
  • While lifestyle changes and vitamin E show mixed results, natural polyphenols, probiotics, and prebiotics are promising.

Conclusions:

  • NAFLD management is complex due to multiple interacting factors.
  • Targeting gut microbiota dysbiosis and oxidative stress offers potential therapeutic avenues.
  • Precision medicine approaches considering individual risk factors are crucial for future NAFLD treatment selection.